U.S. courts will have a full docket of challenging IP cases throughout 2023. Andy Warhol Found. for Visual Arts, Inc. v. Goldsmith, Amgen Inc. v. Sanofi, Interactive Wearables, LLC v. Polar Electro Oy et al., VIP Prods. LLC v. Jack Daniel's Props., Nike, Inc. v. StockX LLC.
With the continuing advancements of cutting-edge technologies such as genome editing (CRISPR) and Non-Fungible Tokens (NFTs) U.S. courts will have a full docket of challenging IP.
The "Therapeutic Drug Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's